Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Guselkumab> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- Guselkumab abstract "Guselkumab is a monoclonal antibody designed for the treatment of psoriasis.Tildrakizumab was designed to block interleukin-23, a cytokine that plays an important role in managing the immune system and autoimmune disease. This drug was developed by Janssen Global Services, LLC.As of March 2014, the drug was in phase II clinical trials for plaque psoriasis. Phase II data released at the 2014 annual conference of the American Academy of Dermatology showed that up to 88% of patients treated with guselkumab achieved a Physician Global Assessment (PGA) score of cleared or minimal disease activity.".
- Guselkumab atcPrefix "none".
- Guselkumab casNumber "1350289-85-8".
- Guselkumab wikiPageID "38694353".
- Guselkumab wikiPageRevisionID "601666646".
- Guselkumab atcPrefix "none".
- Guselkumab c "6402".
- Guselkumab casNumber "1350289".
- Guselkumab chemspiderid "NA".
- Guselkumab h "9864".
- Guselkumab hasPhotoCollection Guselkumab.
- Guselkumab molecularWeight "143.6".
- Guselkumab n "1676".
- Guselkumab o "1994".
- Guselkumab s "42".
- Guselkumab source "u".
- Guselkumab target Interleukin_23_subunit_alpha.
- Guselkumab type "mAb".
- Guselkumab subject Category:Monoclonal_antibodies.
- Guselkumab type Drug.
- Guselkumab type FunctionalSubstance.
- Guselkumab comment "Guselkumab is a monoclonal antibody designed for the treatment of psoriasis.Tildrakizumab was designed to block interleukin-23, a cytokine that plays an important role in managing the immune system and autoimmune disease. This drug was developed by Janssen Global Services, LLC.As of March 2014, the drug was in phase II clinical trials for plaque psoriasis.".
- Guselkumab label "Guselkumab".
- Guselkumab sameAs m.0rfdr2c.
- Guselkumab sameAs Q15708315.
- Guselkumab sameAs Q15708315.
- Guselkumab wasDerivedFrom Guselkumab?oldid=601666646.
- Guselkumab isPrimaryTopicOf Guselkumab.